Armistice Capital »

Onto Innovation shares owned by Armistice Capital

Quarter-by-quarter ownership of Onto Innovation (ONTO) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Onto Innovation

Tip: Access up to 7 years of quarterly data

All positions including Onto Innovation held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Onto Innovation by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.9M 14k 205.07

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Agios Pharmaceuticals (AGIO)
Cytokinetics Com New (CYTK)
Ptc Therapeutics I (PTCT)
Travere Therapeutics (TVTX)
Madrigal Pharmaceuticals (MDGL)
Immunovant (IMVT)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Freshpet (FRPT)
Incyte Corporation (INCY)
Dyne Therapeutics (DYN)
Amazon (AMZN)
Ironwood Pharmaceuticals Com Cl A (IRWD)

View all positions for Armistice Capital

Top funds holding Onto Innovation

Vanguard Group
BlackRock
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
Geode Capital Management
Point72 Asset Management
Paradigm Capital Management
William Blair Investment Management
Ing Investment Management
FMR
Thrivent Financial for Lutherans
D. E. Shaw & Co
Geneva Capital Management
Dimensional Fund Advisors

View all funds holding Onto Innovation